-
Psychedelics Investor Acquires Firm With First-Mover Advantage In Safe Supply Narcotics Sector
Tuesday, January 31, 2023 - 7:47pm | 492Late Tuesday, Origin Therapeutics Holdings Inc. (CSE: ORIG), an investment issuer that has historically focused on psychedelics-industry-related companies announced it had signed a binding Letter of Intent (LOI) to acquire all of the issued and outstanding securities of Safe Supply...